Kidney Disease

BOSTON — While both fast and slow net ultrafiltration rates correlate with mortality in critically ill patients with AKI, the best rate remains unknown, according to a speaker at the National Kidney Foundation Spring Clinical Meetings.

Strive Health and Evolent Care Partners have entered into a new partnership to support 211 primary care providers in Michigan and North Carolina who participate in the Evolent Care Partners’ ACO.

BOSTON — Language barriers to educational materials are an issue patients self-identified as “Hispanic/Latinx” face when considering home dialysis, according to a study presented at the National Kidney Foundation Spring Clinical Meetings.

BOSTON — In a review of the Kidney Disease: Improving Global Outcomes recommendations, a speaker discussed the Kidney Disease Outcomes Quality Initiative commentary on the updated guidelines here.

BOSTON — Trial results show patiromer is effective in controlling hyperkalemia and helps to reduce the risk of using blood pressure medications in patients with chronic kidney disease and heart failure.

BOSTON — Top health equity categories in kidney care include racism and disparities in chronic kidney disease care and kidney transplant care, according to a speaker here who said these can also be addressed with individual strategies.

The National Kidney Foundation awarded Susan T. Crowley, MD, MBA, FASN, FNKF, with the David M. Hume Award, which is the highest honor given by the foundation to a scientist-clinician, according to a press release.

A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic variants underlying inherited kidney diseases, according to data published in the American Journal of Nephrology.

Daniel E. Weiner, MD, nephrologist at Tufts Medical Center and associate professor at Tufts University School of Medicine in Boston, will be honored with the National Kidney Foundation’s J. Michael Lazarus Award.

The FDA rejected Akebia Therapeutics’ anemia drug vadadustat for use in patients with chronic kidney disease, citing concerns about vascular access complications and liver toxicity.